Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Noteable

T.ONC

RE:RE:CAR-T update

October 30, 2024 - https://stockhouse.com/companies/bullboard?symbol=t...

2 days ago

T.ONC

RE:ONCY/ONC.TO - CAR-T - ICIs - Pelareorep & senescent T-cells

October 30, 2024 - " Using CAR-T cells along with oncolytic viruses...

2 days ago

T.ONC

RE:RE:RE:RE:RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies

Should read: " These following 5 cancers (7 indications) are those in...

2 days ago

T.ONC

RE:RE:RE:RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies

These following 7 cancers involve the use of pelareorep as a monotherapy or...

2 days ago

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo

Hotani T, Mizuguchi H, Sakurai F. Systemically administered reovirus-induced...

3 days ago

T.ONC

RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

Hotani et al. demonstrated that reovirus (pelareorep) reduces HIF-1α...

3 days ago

T.ONC

RE:RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

" The opportunity is enormous: Keytruda alone generated $25 billion...

3 days ago

T.ONC

RE:RE:RE:RE:Big pharma is set to keep signing bigger deals in 2024

November 14, 2024 - BioNTech is upping its bet on a PD-L1xVEGF-A bispecific...

3 days ago

T.ONC

HDAC inhibitor resistant cells vulnerable to pelareorep

In a 2020 paper Islam et al. reported that their investigation revealed that...

3 days ago

T.ONC

RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer combo

In 2020, Groeneveldt et al. demonstrated that oncolytic reovirus can be...

3 days ago

T.ONC

RE:RE:RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies

ONCY's pelareorep in pancreatic cancer / Goblet 1 Phase 2 timeline...

4 days ago

T.ONC

RE:RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies

Furthermore GCAR's expected master protocol design should be happening...

5 days ago

T.ONC

RE:RE:RE:RE:RE:How does Accelerated Approval work

Thomas Heinemen described the imminent in ONCY's recent Q3 2024...

5 days ago

T.ONC

RE:RE:RE:How does Accelerated Approval work

Accelerated Approval provides for a drug to receive a conditional...

5 days ago

T.ONC

RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies

Thomas Heineman confirmed that the upcoming (next) Phase 2 mBC and pancreatic...

5 days ago

T.ONC

RE:RE:RE:RE:RE:Over 100 posts by our resident bashing team in the last week

Heineman stated in the Q3 2024 Conference Call: " Our main...

5 days ago

T.ONC

RE:RE:RE:RE:RE:Over 100 posts by our resident bashing team in the last week

Thomas Heineman continued -- "I would now like to move to the Goblet...

5 days ago

T.ONC

RE:RE:RE:RE:Over 100 posts by our resident bashing team in the last week

inthno - you need to listen to the Q3 CC more carefully, since below is what...

5 days ago

T.ONC

RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies

BRACELET-1 efficacy data in HR+/HER2- metastatic breast cancer The recently...

5 days ago

T.ONC

Oncolytics Biotech Announces Key Progress & Upcoming Studies

October 04, 2024 - Oncolytics Biotech® Announces Key Progress and...

5 days ago

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Coppernico Metals Inc

Coppernico Metals Inc T.COPR

Coppernico Metals Inc. is a Canada-based mineral exploration company. The Company is principally engaged in the acquisition ... view more »